000904543 001__ 904543
000904543 005__ 20240625095123.0
000904543 0247_ $$2doi$$a10.3390/molecules26040799
000904543 0247_ $$2ISSN$$a1420-3049
000904543 0247_ $$2Handle$$a2128/30624
000904543 0247_ $$2altmetric$$aaltmetric:99403880
000904543 0247_ $$2pmid$$a33557136
000904543 0247_ $$2WOS$$aWOS:000624192300001
000904543 037__ $$aFZJ-2021-06113
000904543 082__ $$a540
000904543 1001_ $$0P:(DE-HGF)0$$aDomínguez-Mendoza, Elix Alberto$$b0
000904543 245__ $$aDesign, Synthesis, and In Silico Multitarget Pharmacological Simulations of Acid Bioisosteres with a Validated In Vivo Antihyperglycemic Effect
000904543 260__ $$aBasel$$bMDPI$$c2021
000904543 3367_ $$2DRIVER$$aarticle
000904543 3367_ $$2DataCite$$aOutput Types/Journal article
000904543 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1643381304_8634
000904543 3367_ $$2BibTeX$$aARTICLE
000904543 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000904543 3367_ $$00$$2EndNote$$aJournal Article
000904543 520__ $$aSubstituted phenylacetic (1–3), phenylpropanoic (4–6), and benzylidenethiazolidine-2,4-dione (7–9) derivatives were designed according to a multitarget unified pharmacophore pattern that has shown robust antidiabetic activity. This bioactivity is due to the simultaneous polypharmacological stimulation of receptors PPARα, PPARγ, and GPR40 and the enzyme inhibition of aldose reductase (AR) and protein tyrosine phosphatase 1B (PTP-1B). The nine compounds share the same four pharmacophore elements: an acid moiety, an aromatic ring, a bulky hydrophobic group, and a flexible linker between the latter two elements. Addition and substitution reactions were performed to obtain molecules at moderated yields. In silico pharmacological consensus analysis (PHACA) was conducted to determine their possible modes of action, protein affinities, toxicological activities, and drug-like properties. The results were combined with in vivo assays to evaluate the ability of these compounds to decrease glucose levels in diabetic mice at a 100 mg/kg single dose. Compounds 6 (a phenylpropanoic acid derivative) and 9 (a benzylidenethiazolidine-2,4-dione derivative) ameliorated the hyperglycemic peak in a statically significant manner in a mouse model of type 2 diabetes. Finally, molecular dynamics simulations were executed on the top performing compounds to shed light on their mechanism of action. The simulations showed the flexible nature of the binding pocket of AR, and showed that both compounds remained bound during the simulation time, although not sharing the same binding mode. In conclusion, we designed nine acid bioisosteres with robust in vivo antihyperglycemic activity that were predicted to have favorable pharmacokinetic and toxicological profiles. Together, these findings provide evidence that supports the molecular design we employed, where the unified pharmacophores possess a strong antidiabetic action due to their multitarget activation
000904543 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000904543 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000904543 7001_ $$0P:(DE-HGF)0$$aGalván-Ciprés, Yelzyn$$b1
000904543 7001_ $$0P:(DE-HGF)0$$aMartínez-Miranda, Josué$$b2
000904543 7001_ $$0P:(DE-HGF)0$$aMiranda-González, Cristian$$b3
000904543 7001_ $$0P:(DE-HGF)0$$aColín-Lozano, Blanca$$b4
000904543 7001_ $$0P:(DE-HGF)0$$aHernández-Núñez, Emanuel$$b5
000904543 7001_ $$0P:(DE-HGF)0$$aHernández-Bolio, Gloria I.$$b6
000904543 7001_ $$0P:(DE-HGF)0$$aPalomino-Hernández, Oscar$$b7
000904543 7001_ $$0P:(DE-HGF)0$$aNavarrete-Vazquez, Gabriel$$b8$$eCorresponding author
000904543 773__ $$0PERI:(DE-600)2008644-1$$a10.3390/molecules26040799$$gVol. 26, no. 4, p. 799 -$$n4$$p799 -$$tMolecules$$v26$$x1420-3049$$y2021
000904543 8564_ $$uhttps://juser.fz-juelich.de/record/904543/files/molecules-26-00799-v2.pdf$$yOpenAccess
000904543 909CO $$ooai:juser.fz-juelich.de:904543$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000904543 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$aExternal Institute$$b5$$kExtern
000904543 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$aExternal Institute$$b6$$kExtern
000904543 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-HGF)0$$aForschungszentrum Jülich$$b7$$kFZJ
000904543 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$aExternal Institute$$b8$$kExtern
000904543 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000904543 9141_ $$y2021
000904543 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-05-04
000904543 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000904543 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOLECULES : 2019$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000904543 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-05-04
000904543 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-05-04
000904543 920__ $$lyes
000904543 9201_ $$0I:(DE-Juel1)IAS-5-20120330$$kIAS-5$$lComputational Biomedicine$$x0
000904543 9201_ $$0I:(DE-Juel1)INM-9-20140121$$kINM-9$$lComputational Biomedicine$$x1
000904543 980__ $$ajournal
000904543 980__ $$aVDB
000904543 980__ $$aUNRESTRICTED
000904543 980__ $$aI:(DE-Juel1)IAS-5-20120330
000904543 980__ $$aI:(DE-Juel1)INM-9-20140121
000904543 9801_ $$aFullTexts